Introduction {#S1}
============

Being overweight not only affects adults by causing chronic diseases including type 2 diabetes, arterial hypertension, or coronary heart disease, but is also an increasingly widespread health issue in childhood ([@B1], [@B2]). In 2010, 43 million children worldwide were overweight and this number is likely to increase to 60 million by 2020 ([@B3]). Obesity is a risk factor for allergic diseases like bronchial asthma and for various autoimmune diseases ([@B4], [@B5]). It contributes to a low-grade chronic inflammation with higher numbers of macrophages, mast cells, neutrophils, B- and T-cells in adipose tissue ([@B6], [@B7]), but the underlying pathogenesis and complex mutual interactions between immunity and metabolism are not yet completely understood.

T~H~17 cells play a role in autoimmune and allergic inflammation ([@B8]--[@B10]). T~H~17 cells are characterized by retinoic acid receptor-related orphan receptor C (RORC) expression ([@B11], [@B12]) and IL-17A production which attracts and activates neutrophil granulocytes ([@B13]). Physiologically, T~H~17 cells seem to be primarily important for clearance of pathogens, which cannot be fought effectively by T~H~1 nor T~H~2 cells---for example, *Klebsiella pneumoniae, Borrelia burgdorferi*, and helminths or fungi ([@B14], [@B15]). On the other hand, T~H~17 cells contribute to various autoimmune and allergic diseases, for example, inflammatory bowel diseases or bronchial asthma ([@B16]).

Furthermore, there is growing evidence from animal models that T~H~17 cells might also contribute to a low-grade chronically sustained inflammation in obesity. Interestingly, T~H~17 cells were elevated in the spleens of mice with a diet-induced obesity compared to normal weight mice ([@B17]). Likewise, more T~H~17 cells were detected in adipose tissue of obese compared to normal weight mice ([@B18]). Łuczyński et al. found more T~H~17 cells in peripheral blood samples of children with central obesity and diabetes mellitus ([@B19]). However, to our knowledge, none of the published studies on T~H~17 cells in overweight was controlled for potentially coinciding chronic inflammatory disease like bronchial asthma or autoimmunity. Thus, it remains unknown whether elevated T~H~17 cells in overweight individuals are directly linked with overweight or are a consequence of associated chronic inflammatory diseases ([@B20]). In this study, we wanted to test the hypothesis that the T~H~17 cell frequency is elevated in the peripheral blood of overweight children without allergic or autoimmune disease.

Materials and Methods {#S2}
=====================

The study was performed at the *Department of Pediatrics, Philipps University, Marburg*, and was approved by the local Ethics Committee. Written informed consent was obtained from parents and in older children additionally from themselves. Children admitted to the outpatient clinic because of adiposity or non-inflammatory conditions like headache, elective surgery, or abdominal pain were screened for eligibility. Children were excluded from our study when they were younger than 4 years or older than 17 years old, had asthma, atopic dermatitis, allergic rhinoconjunctivitis, or any autoimmune disease in their medical history. Symptoms of an acute infection during the previous 2 weeks led to exclusion as well as clinical symptoms of a current infection, current C-reactive protein elevation or leukocytosis. Being overweight was defined as a body mass index (BMI) ≥90th percentile, while children with a BMI \< 90th percentile were included in our non-overweight control group. BMI percentiles were assessed with percentiles for German children published by Kromeyer-Hauschild et al. ([@B21]).

Flow Cytometry {#S2-1}
--------------

2.6 ml of venous blood were collected after informed consent during a routinely performed venipuncture or during routine placement of a peripheral venous catheter.

Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque gradient (PAA, Linz, Austria) and were stimulated in a 12-well plate in X-VIVO 15 (X-VIVO 15 w/o Gentamycin and Phenol Red, Lonza, Velvier, Belgium) with Ionomycin (Sigma Aldrich Chemie, Steinheim, Germany) for 4 h (37°C, 5% CO~2~). Brefeldin A (eBioscience, San Diego, CA, USA) was added after 3 h. After staining these cells with anti-CD3 (FITC) and anti-CD4 (PE) antibodies (R&D Systems, Minneapolis, MN, USA), the PBMCs were fixated, permeabilized, and stained intracellularly with anti-IL-17A antibody (APC) (Flow Cytometry Fixation and Permeabilization Buffer Kit I, R&D Systems, Minneapolis, MN, USA).

Flow cytometry was performed on a 4-color FacsCalibur flow cytometer (BD Biosciences) using summit 4.3 software (Beckman Coulter, Krefeld, Germany). Gates were preset and the measurements were performed blinded for sample identity. T~H~17 cells were defined as CD3^+^CD4^+^IL-17A^ic+^ ([@B22]) and were evaluated as percentage of T~H~ lymphocytes (CD3^+^CD4^+^) (Figure [1](#F1){ref-type="fig"}).

![Definition of T~H~17 cells: peripheral blood mononuclear cells were stimulated with Ionomycin *in vitro* followed by staining with anti-CD3 (FITC), anti-CD4 (PE), and anti-IL-17A (APC). Representative flow cytometry analyses of a normal weight **(A)** and overweight **(B)** child, respectively.](fimmu-08-01543-g001){#F1}

RNA Isolation, cDNA Transcription, and Real-time PCR {#S2-2}
----------------------------------------------------

An aliquot of the stimulated PBMCs was used for messenger RNA (mRNA) isolation with TriFast (peqlab, Erlangen, Germany) and subsequent DNase I digestion (Desoxyribonuclease I, Amplification Grade, invitrogen, Darmstadt, Germany), following the manufacturer's instructions, respectively. cDNA was synthesized from 2 µl of mRNA using Omniscript R Kit (QIAGEN, Hilden) and Oligo(dT)~18~ primer and RiboLock RNase Inhibitor (Thermo Fisher Scientific, Nidderau, Germany). cDNA concentration was measured on a NanoDrop 2000c (Thermo Fisher Scientific, Nidderau, Germany) and was diluted by addition of RNase free water (Water, Mol Bio grade DNase-, RNase-, and Protease-free; 5 PRIME, Hamburg, Germany) into a concentration of 1,000 ng/µl.

Real-time PCR was performed on each cDNA sample as duplicate to determine relative expression of RORC- and IL-17A-mRNA and was normalized by Elongation factor 1-α (EF-1-α) as a housekeeping gene and calculated by the 2^−ΔΔCt^ formula. EF-1-α was used because its expression in T cell culture is more stable than other housekeeping genes such as glyceraldehyde 3-phosphate dehydrogenase ([@B23]). 4.7 µl fluorochrom (SsoAdvanced SYBR Green Supermix; Biorad Laboratories, Munich, Germany), 4.2 µl RNase free water (Water, Mol Bio grade DNase-, RNase-, and Protease-free; 5 PRIME, Hamburg, Germany), 0.1 µl primer mix (all eurofins MWG Synthesis, Ebersberg, Germany) and 1 µl template were used per well of a 96-well plate. The following primers were used for real-time PCRs:

  ---------------- -------------------------------
  EF-1-α-primer:   5′-CTGAACCATCCAGGCCAAAT-3′;\
                   5′-GCCGTGTGGCAATCCAAT-3′

  RORC-primer:     5′-GCCTTTCATCATCATCTCTGC-3′;\
                   5′-GAAGATCTGCAGCCTTTCCA-3′

  IL-17A-primer:   5′-CCCCAGTTGATTGGAAGAAA-3′;\
                   5′-TTCGTGGGATTGTGATTCCT-3′.
  ---------------- -------------------------------

An iQ5 (iQ5 Multicolor Real Time PCR Detector System; Biorad Laboratories, Munich, Germany) was used as thermocycler for real-time PCR. Real-time PCR analyses were executed with Bio-rad iQ5 Standard Edition software (Biorad Laboratories, Munich, Germany).

Statistical Analysis {#S2-3}
--------------------

Statistical analyses were performed using Prism 5.0 (GraphPad Software, La Jolla, CA, USA). Group differences were tested using either the two-tailed Student's *t*-test or, in case of non-normally distributed data, the Mann--Whitney *U* test. Violation of the normality assumption was assessed by Kolmogorov--Smirnov test. Analogously, Pearson and Spearman correlation was calculated for surface and intracellular staining for normally or non-normally distributed data, respectively. Differences with *p*-values of *p* \< 0.05 were deemed significant.

Results {#S3}
=======

Subjects {#S3-1}
--------

65 children between 4 and 17 years of age were enrolled in our study---15 were overweight and 50 were not overweight as controls. The overweight children had a mean BMI-percentile of 97.12 ± 2.68 in comparison to 39.74 ± 27.04 in the control group. The patients' anthropometric data are shown in Table [1](#T1){ref-type="table"}.

###### 

Characteristics of the study subjects.

  Study group                                                Overweight       Controls         *p*
  ---------------------------------------------------------- ---------------- ---------------- ---------------
  Number                                                     15               50               
  Female No. (%)                                             8 (53%)          29 (58%)         n.s.
  Age (mean, SD) \[years\]                                   11.96 (3.21)     10.18 (3.15)     n.s.
  Height (mean, SD) \[cm\]                                   150.39 (15.83)   140.77 (18.75)   n.s.
  Weight (mean, SD) \[kg\]                                   60.00 (20.52)    33.45 (12.41)    *p* \< 0.0001
  Body mass index (BMI) (mean, SD) \[kg/m^2^\]               26.75 (4.08)     16.73 (2.39)     *p* \< 0.0001
  BMI-percentile (mean, SD) \[%\]                            97.12 (2.68)     39.74 (27.04)    *p* \< 0.0001
  Leukocytes (mean, SD) \[G/l\] cells = (mean, SD) \[G/l\]   7.13 (1.41)      5.71 (1.82)      n.s.

*n.s., not significant*.

According to the inclusion criteria, all patients had a negative history of asthma, atopic dermatitis, allergic rhinoconjunctivitis, and autoimmune diseases. None of the children had an acute infection during the 2 weeks prior to the study enrollment as confirmed by medical history. A current infection was excluded by physical examination and measurement of C-reactive protein.

T~H~17 Cell Frequency Is Elevated in Overweight Children {#S3-2}
--------------------------------------------------------

Flow cytometry analysis showed significantly higher T~H~17 cell frequencies after stimulation in overweight children than in non-overweight controls \[34.7 ± 1.54% (mean ± SEM), and 25.4 ± 2.38%\], respectively (*p* = 0.0023; Figure [2](#F2){ref-type="fig"}A).

![**(A)** Overweight children had significantly higher T~H~17 cell frequencies, defined as IL-17A^ic+^ T~H~ cells, than controls. **(B)** Positive correlation between circulating T~H~17 cells and body mass index, solid regression line (*r* = 0.42, *p* = 0.0005). Filled dots: non-overweight controls, dotted regression line (*r* = 0.17, *p* = 0.27). Empty dots: overweight children, dashed regression line (*r* = 0.27, *p* = 0.33).](fimmu-08-01543-g002){#F2}

T~H~17 cell frequencies correlated positively with the absolute BMI (*r* = 0.42, *p* = 0.0005, Figure [2](#F2){ref-type="fig"}B). In contrast, IL-17 expression was similar among CD3^+^CD4^−^ cells from non-overweight controls (45.9 ± 16.0) and overweight children (50.1 ± 17.3%) (*p* = 0.384, data not shown). Thus, we did not find signs of an unspecific stimulation of IL-17 production in non-T~H~17 cells. Separate analyses of the overweight and non-overweight groups yielded no significant correlation between BMI and T~H~17 cell frequencies (*r* = 0.27, *p* = 0.33; and *r* = 0.17, *p* = 0.23, respectively, Figure [2](#F2){ref-type="fig"}B).

RORC- and IL-17A Expression Is Elevated in Overweight Children {#S3-3}
--------------------------------------------------------------

Real-time PCR revealed that the relative mRNA expression of the transcription factor RORC and of IL-17A, which are both associated with the T~H~17 cell lineage, were 1.8- and 2.3-fold elevated in stimulated PBMCs from overweight children compared to non-overweight children, respectively (1.76 ± 0.35 versus 1.00 ± 0.13; *p* = 0.013; Figure [3](#F3){ref-type="fig"}A and 2.27 ± 0.72 versus 1.00 ± 0.16; *p* = 0.014; Figure [3](#F3){ref-type="fig"}B).

![Messenger RNA expression of **(A)** transcription factor receptor-related orphan receptor C (RORC) (1.76 ± 0.35 versus 1.00 ± 0.13; *p* = 0.013) and **(B)** IL-17A (2.27 ± 0.72 versus 1.00 ± 0.16; *p* = 0.014) by PBMCs from non-overweight controls and overweight patients.](fimmu-08-01543-g003){#F3}

Discussion {#S4}
==========

In this study, we observed that in the absence of acute or chronic inflammatory diseases, the frequency of circulating T~H~17 cells was significantly increased in overweight children compared to non-overweight controls and there was a positive correlation between T~H~17 cell frequency and BMI. In agreement with this, we registered a significantly higher expression of RORC- and IL-17A-mRNA transcripts after stimulation in PBMCs from overweight children.

Overweight and chronic inflammatory diseases are imprinted during the fetal and early postnatal periods, and the metabolic and inflammatory phenotypes of these diseases occur during the dynamic development of the immune system in children and juveniles ([@B24]). It is known from other studies that biomarkers associated with overweight may differ significantly between obese juveniles and adults \[e.g., Ref. ([@B25])\]. This demonstrates that findings on metabolic and inflammatory diseases cannot be extrapolated from adults to children without restrictions. Thus, we chose to study the frequency of T~H~17 cells in children and juveniles before the metabolism and the immune system reach maturity.

Łuczyński et al. recently reported elevated T~H~17 cells in peripheral blood of children with central obesity and in children with diabetes mellitus I ([@B19]). Since obesity is linked with an increased risk for allergic and autoimmune diseases and T~H~17 cells were increased in patients with such conditions, we studied obese individuals without concomitant allergies and autoimmune diseases ([@B5], [@B6], [@B8]--[@B10], [@B22]).

The role of T~H~17 cells in the development of allergies is still under investigation. Probably, various pro-inflammatory and anti-inflammatory subpopulations of T~H~17 cells play unique roles in orchestrating the allergic inflammation ([@B26]). The cytokine production of T~H~17 cells appears to be more dynamic than previously anticipated depending on the signals provided by the microenvironment ([@B26]). Compared to healthy controls, IL-17A expression was higher in cultured T-lymphocytes from patients with mild--moderate asthma and persistent allergic rhinitis and decreased after anti-inflammatory therapy with inhalative corticosteroids ([@B22]). IL-17A influences the acute inflammatory response by upregulating IL-8 secretion in airway epithelial cells and also initiates airway remodeling by affecting the airway smooth muscle cells ([@B27]).

Since BMI standard values vary throughout childhood and between various ethnicities, we used the German percentiles that were obtained from measurements of 34,422 children ([@B21]). Due to the great variance of T~H~17 cell frequencies, they overlap between the overweight and non-overweight groups (Figure [2](#F2){ref-type="fig"}A). Intriguingly, BMI and T~H~17 cell frequency apparently do not show a linear correlation, since we found no significant correlation between BMI and T~H~17 cells when analyzing overweight and non-overweight children separately. This could indicate that the T~H~17 bias develops above a threshold BMI that provides a pro T~H~17 inflammatory environment or that the sample sizes were too small within the subgroups.

One limitation of the study is that due to the limited cell numbers in the pediatric samples, the expression of RORC and IL-17A transcripts were investigated in unsorted PBMCs. However, multiple previous studies have confirmed that CD4^+^ T cells are the major (although not exclusive) source of IL-17 and RORC expression in similar experimental settings as ours \[e.g., Ref. ([@B8], [@B22])\]. In accord with this, we found that the number of IL-17^ic+^ cells did not increase among CD3^+^CD4^−^ cells but only among CD3^+^CD4^+^ cells after *in vitro* stimulation (data not shown).

T~H~ cell subsets are defined by characteristic expression patterns of surface antigens, cytokines, and master transcription factors. For instance, human T~H~1 cells produce interferon-γ and Tbet ([@B28]), T~H~2 cells produce IL-4 and GATA3 ([@B29], [@B30]), and T~H~17 cells produce IL-17A and RORC, which is orthologous to retinoic acid receptor-related orphan receptor γt (RORγt) in mice ([@B8], [@B31]). RORC as a master transcription factor is necessary for the differentiation of naïve T~H~ cells into T~H~17 cells and is important for the production of T~H~17 cell effector cytokines in humans ([@B32], [@B33]).

In murine models, RORγt could induce IL-17A production *in vitro* ([@B31]). RORγt- and RORα-loss results in a total T~H~17 deficiency, single RORγt-loss in a relative one. In human T~H~17 cells, similar effects were observed: RORC-inhibition led to a reduced IL-17A-production and RORC-overexpression to an elevated differentiation into T~H~17 cells ([@B34]).

As effector memory T~H~17 cells, they secrete IL-21, IL-22, and IL-26, and express CCL20, CCR6, and CD161 ([@B12], [@B35], [@B36]). Multiple different staining protocols have been deduced from these lineage specific characteristics, but the complexity and insufficient understanding of the T~H~17 cell subsets precluded the development of a universally accepted standard definition. In this study, the staining protocol defines T~H~17 cells as CD3^+^CD4^+^IL-17A^ic+^ lymphocytes after stimulation---which is a common definition of flow cytometric assessed T~H~17 cells---with the strong, but unspecific stimulus Ionomycin ([@B22]). Possibly, a fraction of the CD3^+^CD4^+^IL-17A^ic+^ cells might not be classical T~H~17 cells but NKT cells, some of which can be CD4^+^ and may have the potential to express IL-17; however, according to previous work, this fraction is probably very small ([@B37]). It is unlikely that this short time culture has a polarizing effect toward the development of T~H~17 cells but it stimulates IL-17A expression in those cells that have already undergone polarization ([@B38]). According to previous studies with similar protocols, it is also unlikely that non-IL-17A-expressing T~H~ cells vanish more quickly than their IL-17A-positive counterparts ([@B38]). Probably, less T~H~17 cells are actively producing IL-17A *in vivo* than *in vitro* following stimulation, since T~H~17 cells are characterized by their ability to produce IL-17A and not by actively producing it continuously.

Obesity does not only interfere with metabolic, but also with immunological pathways and is associated with low-grade chronic inflammation ([@B39]). Several groups reported an association between obesity and T~H~17 cells in mouse models. Winer et al. induced obesity by high fat diet and measured elevated T~H~17 cells and IL-17A production in murine spleens ([@B17]), and Chen et al. detected more T~H~17 cells in adipose tissue of obese mice compared to normal weight controls ([@B18]). Furthermore, T~H~17 cells were elevated in a model of obese mice that developed inflammatory arthritis. Thus, T~H~17 cells might contribute to the pathogenesis of inflammatory arthritis in obese mice ([@B40]). Some studies found elevated frequencies of T~H~17 cells or their cytokines in children with type 1 diabetes mellitus ([@B41], [@B42]). IL-17A secretion by human T~H~17 cells was enhanced in the presence of adipose-derived stem cells *in vitro* ([@B43]). Dendritic cells, sorted from subcutaneous adipose tissue of obese patients, can induce T~H~17 cell differentiation *in vitro* ([@B44]). Interestingly, IL-17A gene expression in CD3^+^ cells from subcutaneous adipose tissue was elevated overweight patients compared to normal weight patients ([@B44]). In lean state, M2 macrophages, T~reg~ cells, T~H~2 cells, and NKT cells predominate, while M1 macrophages, T~H~1 cells, B cells, mast cells, and neutrophils predominate in obese individuals ([@B6], [@B39]). Adipose tissue produces adipokines which predominantly have a pro-inflammatory effect. Some of the identified adipokines include IL-6, IL-8, TNF-α, and IL-18 ([@B39]). TNF-α and IL-6 are required for T~H~17 cell differentiation ([@B45]). This pathway potentially leads to an increase of T~H~17 cell frequency in obese individuals. Leptin receptor signaling seems to be a further requirement for murine T~H~17 cell differentiation ([@B46]). The serum leptin concentration is elevated in obese individuals. Moreover, in humans, being overweight is associated with higher amounts of circulating neutrophils, which are attracted, among other things, by IL-17A ([@B14], [@B47]--[@B49]). In addition, elevated levels of myeloperoxidase were found in obese women, which coincide with higher levels of neutrophils as well ([@B47]).

Obesity can be a reason as well as a consequence of oxidative stress ([@B50]). One can hypothesize that oxidative stress might in part cause the association between obesity and allergies since obesity is associated with an overload of antioxidant compounds that promote a T~H~2-biased immune state as known from allergies ([@B50]). In support of this hypothesis, oxidative stress led to upregulated IL-17A serum levels in mice ([@B51]). In systemic lupus erythematosus, oxidative stress can cause mammalian target of rapamycin (mTOR) activation, and this mTOR activation in turn is suggested to stimulate T~H~17 cell differentiation ([@B52], [@B53]).

Conclusion {#S5}
==========

In this study, we observed an elevated T~H~17 cell frequency as well as elevated RORC- and IL-17A-mRNA expression in peripheral blood of overweight children without allergic asthma, allergic rhinoconjunctivitis, atopic dermatitis, or autoimmune disease. To our knowledge, this is the first study on T~H~17 cells in overweight pediatric patients that excludes potentially confounding chronic inflammatory diseases other than obesity. Elevated T~H~17 cells might contribute to the pro-inflammatory state in overweight children. Further studies are needed to specify the underlying pathomechanism of this association. In conclusion, future studies on the frequency of circulating T~H~17 cells should control for the BMI.
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